CYTUNEPHARMA

cytunepharma-logo

Cytune is a private company developing a broad portfolio of novel immunotherapeutic agents to treat primarily cancer. Cytune’s hedge relies on a proprietary scientific breakthrough in immunology: effective form of a major human immunocytokine: trans-presentation mechanism of a critical immune factor: IL-15 Cytune’s proprietary most advanced proprietary compound, CYP 0150, is a human interleukin-15 uniquely linked to its effector. Cytune is further developing conjugated monoclonal antibodies linked to CYP 0150. Cytune was founded in 2007 and is managed by Dr. David Bechard, a successful serial biotech entrepreneur and Dr. Yannick Jacques, Director of Public Research at the Inserm (National Institute for Health and Medical Research)

#SimilarOrganizations #People #Financial #Website #More

CYTUNEPHARMA

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2007-01-01

Address:
Nantes, Pays De La Loire, France

Country:
France

Website Url:
http://www.cytunepharma.com

Total Employee:
1+

Status:
Active

Contact:
+33 2 40 08 47 23

Total Funding:
6.66 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS


Similar Organizations

datahow-logo

DataHow

DataHow offers digital solutions and consulting for process screening, monitoring, optimization, control and scale-up.

exponential-biotherapies-logo

Exponential Biotherapies

Exponential Biotherapies develops therapeutics to attenuate overreactions of the immune system.

Current Employees Featured

guy-de-martynoff_image

Guy de Martynoff
Guy de Martynoff Chief Technical Officer/Chief Manufacturing Officer @ CytunePharma
Chief Technical Officer/Chief Manufacturing Officer
2009-08-01

david-béchard_image

David Béchard
David Béchard Founder, President, CEO, and CSO @ CytunePharma
Founder, President, CEO, and CSO
2007-11-01

Founder


david-béchard_image

David Béchard

not_available_image

Yannick Jacques

Investors List

ppfgroup_image

PPF Group

PPF Group investment in Venture Round - CytunePharma

ppfgroup_image

PPF Group

PPF Group investment in Venture Round - CytunePharma

abab-atlantic-business-angels-booster_image

ABAB (Atlantic Business Angels Booster)

ABAB (Atlantic Business Angels Booster) investment in Venture Round - CytunePharma

Official Site Inspections

http://www.cytunepharma.com

  • Host name: 185.183.11.92
  • IP address: 185.183.11.92
  • Location: Czechia
  • Latitude: 50.0848
  • Longitude: 14.4112
  • Timezone: Europe/Prague

Loading ...

More informations about "CytunePharma"

CYTUNE PHARMA Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for CYTUNE PHARMA of NANTES, PAYS DE LA LOIRE. Get the latest business insights from Dun & …See details»

SOTIO and PPF complete acquisition of Cytune Pharma

Aug 30, 2018 Cytune Pharma develops IL-15 based therapies for the treatment of cancer. The lead molecule of Cytune’s pipeline, SO-C101 (RLI-15), is a human fusion protein of IL-15 and …See details»

CytunePharma - 2025 Company Profile - Tracxn

Mar 12, 2025 CytunePharma - Developing immunostimulatory agents (interleukin-15) & conjugated mAbs for cancer. Raised a total funding of $11.6M over 3 rounds from 4 investors.See details»

CYTUNE Trademark of CYTUNE PHARMA S.A.S.. Application …

Based on CYTUNE PHARMA S.A.S., the CYTUNE trademark is used in the following business: Scientific and technological services, research and design relating thereto; industrial analysis …See details»

Cytune Pharma SAS - life-sciences-europe.com

Cytune Pharma is a private company dedicated to the research and development of a portfolio of novel immunotherapeutic agents which expand and activate immune responses to treat …See details»

CytunePharma - VentureRadar

Jul 10, 2016 CytunePharma VentureRadar profile. Find out more about CytunePharma including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»

Cytune Pharma SAS - Drug pipelines, Patents, Clinical trials - Synapse

May 8, 2025 Explore Cytune Pharma SAS with its drug pipeline, therapeutic area, technology platform, 2 news, and 11 literature, Disease Domain:Neoplasms, Technology Platform:Peptide …See details»

SOTIO acquires Cytune Pharma | Pharmasources.com

SOTIO, a biotechnology company owned by the PPF Group, announces today the completion of the acquisition of Cytune Pharma by PPF. It will continue to develop the lead program SO …See details»

CYTUNE PHARMA - explore.openaire.eu

Organization, country, CYTUNE PHARMACYTUNE PHARMAL'objectif de ce programme est de développer de nouveaux agents immunothérapeutiques propriétaires pour apporter de …See details»

Cytune Pharma S.A.S. - BioCentury Company Profiles - BCIQ

Cytune Pharma S.A.S. - BioCentury Company Profiles for the biopharma industrySee details»

CYTUNE PHARMA - Societe.com

Jun 16, 2025 CYTUNE PHARMA à NANTES (500998703) RCS, SIREN, SIRET, bilans, statuts, chiffre d'affaires, dirigeants, cartographie, alertes, annonces légales, enquêtes, APE, NAF ...See details»

CytunePharma Company Information - Funding, Investors, and …

Get information on funding, investors, industries, and more for CytunePharma. See CytunePharma company profile and funding data.See details»

SOTIO and PPF Complete Acquisition of Cytune Pharma

SOTIO, a biotechnology company owned by the PPF Group, announces today the completion of the acquisition of Cytune Pharma by PPF.See details»

Cytune Pharma Lands €6 Million Deal to Advance Immuno …

Jun 29, 2016 Cytune Pharma SAS, a French biotech company focused on research and development of novel immunotherapies for cancer treatment, has secured a 6 million euro …See details»

Cytiva

Meet the leadership team driving Cytiva's mission to advance and accelerate therapeutics across the globe.See details»

Logo, A Canada Trademark of CYTUNE PHARMA S.A.S.

Logo is a canadian trademark and brand of CYTUNE PHARMA S.A.S., F-44100 Nantes,FRANCE. This trademark was filed to the Canadian Intellectual Property Office on …See details»

Cytune Pharma secures €6M in financing to advance lead immuno …

June 29, 2016 Source: Cytune Pharma’s Press ReleaseNantes, June 29, 2016 – Cytune Pharma SAS, a French biotechnology company focused on developing novel immunotherapies for the …See details»

CA2938649 - Drug Targets, Indications, Patents - Synapse

Jul 22, 2025 CA2938649, Initially developed by Cytune Pharma SAS, Now, its global highest R&D status is Discovery, Therapeutic Areas: Neoplasms, Active Indication: Neoplasms, Active …See details»

CYTUNE, An Australia Trademark of CYTUNE PHARMA S.A.S.

CYTUNE is an australia trademark and brand of CYTUNE PHARMA S.A.S., ,FRANCE. This trademark was filed to IP Australia on Monday, May 31, 2021. The CYTUNE is under the …See details»

Similar companies to CytunePharma | VentureRadar

Companies like CytunePharma. Similar companies and competitors including the VentureRadar Innovation and Growth scores, Company Information, Location and more.See details»

linkstock.net © 2022. All rights reserved